Although the US FDA recently banned the sale of kits used to correct a common pelvic floor problem in women called uterovaginal prolapse, a recent novel study called “SUPeR” sponsored by the Pelvic Floor Disorder Network, in partnership with RTI International, and led...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
